1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. Limited Competition: Knockout Mouse Production and Phenotyping Project (UM1) Clinical Trial Not Allowed

Limited Competition: Knockout Mouse Production and Phenotyping Project (UM1) Clinical Trial Not Allowed

The purpose of the Knockout Mouse Phenotyping Project (KOMP2) is to produce a comprehensive resource of null-mutant mice, and associated phenotype data, for the purpose of elucidating functional information for each protein-coding gene in the mammalian genome. This Funding Opportunity Announcement (FOA) solicits applications for production and phenotyping centers that will make maximum progress toward completion of KOMP2 in a final five-year project period. The specific objectives are to generate approximately 1,200 mutant mouse lines using CRISPR/Cas9 technology, perform a series of phenotyping assays, cryopreserve germplasm, and make mice and data readily available to the research community.
This is a limited competition RFA. Only recipient organizations funded under (RFA-RM-15-017) are eligible to apply.

Funding Opportunity Details

RFA-HG-21-036
None

Key Dates

10/1/2021

November 1, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.